Clinical Trial Update: Phase I Study of Oral Darinaparsin (ZIO-101-C)in Advanced Solid Tumors and Non-Hodgkin's Lymphomas [Phase 1]

View source ↗

Summary

This is a Phase I clinical trial update of oral darinaparsin (ZIO-101-C) in patients with advanced solid tumors and Non-Hodgkin lymphoma; no results are provide…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma
• Solid Tumors

Drugs mentioned

• Darinaparsin (darinaparsin)

Snippet

Sponsor: Alaunos Therapeutics | Conditions: Advanced Cancer | Phase 1 | Status: UNKNOWN